Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC4353 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Mononuclear Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Vitiligo |
Storage | Liquid Nitrogen |
Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
Human Vitiligo Peripheral Blood Mononuclear Cells are a population of mononuclear cells isolated from the peripheral blood of patients with vitiligo, mainly including lymphocytes (T cells, B cells, NK cells) and monocytes. Morphologically, PBMCs are typically round or oval. In vitiligo, PBMCs (especially autoreactive CD8+ T cells) mediate cytotoxicity by recognizing melanocyte antigens (such as tyrosinase-related protein 1/2), leading to melanocyte destruction and skin depigmentation. In addition, abnormal function of regulatory T cells (Treg) and increased secretion of proinflammatory cytokines (such as IFN-γ, TNF-α) further drive autoimmune responses.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Vitiligo Peripheral Blood Mononuclear Cells can be used to investigate the immunological mechanism of vitiligo. They can also be used to evaluate the cytotoxic effect of PBMCs on melanocytes, thereby identifying potential pathogenic T cell subsets. These cells can also be applied to test the efficacy of immunomodulatory therapies (such as JAK inhibitors, IL-15 antagonists) and evaluate their inhibitory effects on T cell activation and cytokine release.